Long-term efficacy and pharmacodynamic parameter analysis in pretreated KRAS-mutant metastatic colorectal carcinoma (mCRC) patients treated with RG7160 (GA201), an antibody-dependent cellular cytotoxicity (ADCC)-enhanced monoclonal anti-EGFR antibody.
Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jean-Pierre Delord, Josep Tabernero, Rocio Garcia-Carbonero, Andres Cervantes-Ruiperez, Carlos Alberto Gomez-Roca, Yann Berge, Jaume Capdevila, Jesus Corral Jaime, Desamparados Roda Perez, Sophie Golding, David Oppenheim, Sophia Soehrman Brossard, Christoph Mancao, Farzin Farzaneh, Alexandre Passioukov, Luigi Manenti, Marion Gabriele Ott, Jean-Charles Soria
Institutions: Institut Claudius Regaud, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Hospital Universitario Virgen del Rocío, Universitat de València, INCLIVA Health Research Institute, F. Hoffmann-La Roche AG, King's College London, Roche (China), Institut Gustave Roussy
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2589972844